SCHEMBL22050403

SCHEMBL22050403

CC1(c2ccccc2)c2ccc(N)cc2Oc2cc(N)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.42
KMT2A Q03164 6/20 0.42
MAPT P10636 6/20 0.42
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 5/20 0.42
FTO Q9C0B1 1/20 0.38
CHEK1 O14757 1/20 0.37
PRKD3 O94806 1/20 0.37
MAP4K4 O95819 1/20 0.37
RET P07949 1/20 0.37
MET P08581 1/20 0.37
PDGFRA P16234 1/20 0.37
FLT1 P17948 1/20 0.37
LTK P29376 1/20 0.37
PRKX P51817 1/20 0.37
NEK2 P51955 1/20 0.37
JAK3 P52333 1/20 0.37
BTK Q06187 1/20 0.37
MAP4K2 Q12851 1/20 0.37
DYRK1A Q13627 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22043880 0.91 HSD17B10 (0.41) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL22050663 0.83 ALDH1A1 (0.46) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL22050397 0.83 ALDH1A1 (0.44) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL3471424 0.82 MAPT (0.44) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL30187261 0.82 MAPT (0.44) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL12747274 0.80 MAPT (0.40) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL418120 0.79 MAPT (0.42) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL21189654 0.79 MMP2 (0.34) MMP2MMP9HTR6
SCHEMBL9810556 0.79 FTO (0.48) MEN1KMT2AMAPTALDH1A1FTO
SCHEMBL15713397 0.77 MMP2 (0.41) ALDH1A1LMNAMMP2MMP9GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200172470-A1 NOVEL (POLY)AMINE COMPOUND, RESIN AND CURED PRODUCT MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2020-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200172470-A1 NOVEL (POLY)AMINE COMPOUND, RESIN AND CURED PRODUCT PAM, CBR1, KDM1A MEN1 3096/4885KMT2A 55/4885MAPT 3112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.